UroGen Pharma Ltd. (URGN)
28.18
+0.93
(+3.41%)
USD |
NASDAQ |
Jun 09, 16:00
28.18
0.00 (0.00%)
After-Hours: 20:00
UroGen Pharma SG&A Expense (Quarterly) : 51.49M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Savara, Inc. | 15.57M |
| United Therapeutics Corp. | 156.60M |
| Puma Biotechnology, Inc. | 18.42M |
| TG Therapeutics, Inc. | 88.22M |
| MetaVia, Inc. | 1.924M |